KDUS CEO: Someone probably alerted to your earlier statement re: no CEO but in case not Cadus already has a new man...
Tarrytown, NY, July 6, 1998 -- Cadus Pharmaceutical Corporation
(Nasdaq: KDUS) announced today that Dr. Charles Woler has accepted the
positions of President and Chief Executive Officer of Cadus. Dr. Woler, 49, is a doctor of medicine and holds a Ph.D. in Clinical Pharmacology and an MBA.
Most recently, Dr. Woler was General Manager of Bouchara Group, responsible in particular for its Pharmaceutical OTC division and for research and development. Dr. Woler's career has also included serving as Chairman of Europe-Pharmaceuticals for SmithKline Beecham and as Chairman of Hoffmann-La Roche (France) Pharma, Diagnostics, Vitamins and Fine Chemicals.
He has been an associate professor of strategy management and organization at the University of Paris and serves on a variety of public and private advisory boards.
Carl Icahn, a director of Cadus, stated, "I am extremely pleased to have a person with Dr. Woler's leadership abilities, technical background and commercial experience accept the chief executive officer position with Cadus."
Dr. Woler said, "Cadus has a technology platform recognized by its peers for its excellence and has bright and committed people. I have confidence in the future of the company and am enthusiastic about its research potential." |
